AI continues to gain momentum in healthcare, and physicians’ openness to using these tools has increased over the past 2 years. Our latest findings show that while physicians are ready and eager to adopt AI tools, most haven’t yet received meaningful support from pharma companies. This has remained unchanged over the past 2 years, leaving a clear gap between physicians’ enthusiasm and the assistance available to them. Discover the full insights in our new infographic showcasing physicians’ perspectives on AI and the untapped opportunities for pharma to help move adoption forward....
From quick information searches to assisting during consultations, AI tools are becoming increasingly important in physicians' practice. Our latest findings reveal that physicians are widely using these technologies in their practice, and most believe they’ll have a positive impact on healthcare. Yet as AI becomes more accessible, doctors are spending more time correcting patient misconceptions. See the full picture in our new infographic exploring how physicians are adopting AI, and where caution remains....
Real-world evidence (RWE) is no longer a secondary data source, it’s becoming a core input in oncology treatment decisions. In a new survey of Canadian and U.S. oncologists, MD Analytics explores how RWE is being used in clinical practice, the scenarios where it’s most valuable, and what challenges still exist in applying it effectively. Our latest infographic reveals where oncologists see the greatest benefit from RWE, how it supports complex decision-making, and what pharmaceutical companies can do to improve access, data quality, and clinical relevance....
In oncology, the pace is fast and the competition fierce. Leaders stand out not only for groundbreaking therapies but also for building trust, brand recognition, and robust patient support programs. MD Analytics surveyed U.S. and Canadian oncologists to learn which companies are in the lead and why. The findings reveal that perceived leadership goes beyond science alone; it’s about a commitment to patient care that resonates with both clinicians and patients. View our latest infographic and blog to see how top companies are positioning themselves to maintain momentum and secure their place at the front of the field....
Oncologists in the U.S. and Canada value different qualities in sales reps and MSLs. Our latest findings highlight where credibility, expertise, and engagement stand out and which companies earn the strongest recognition....
A recent survey of oncologists in North America reveals a rising trend: more patients are being diagnosed with solid tumor cancers at a younger age. Backed by recent epidemiological studies, this shift is particularly evident in breast and colorectal cancers. This demographic change is expected to impact treatment strategies, patient management, and how pharmaceutical companies support and communicate with younger patients. Explore the infographic to learn more about the implications for oncology care....
Medical Science Liaisons (MSLs) play a crucial role in connecting scientific advancements with healthcare professionals. Our latest research highlights what physicians value most in MSL interactions, where key gaps exist, and which companies are leading in specific therapeutic areas. Explore our new infographic for insights on strengthening MSL impact and delivering greater value to healthcare professionals....
Physician interactions with pharmaceutical sales reps have evolved significantly since the pandemic. While in-person meetings remain valuable, many doctors now appreciate the flexibility of multiple engagement options. Ensuring a balance between virtual and face-to-face interactions is key to meeting physician preferences. Explore our latest infographic for insights into how sales rep interactions are shaping physician engagement today....
We surveyed US and Canadian physicians to uncover which medical conferences deliver the most value and which fall short. Interestingly, high attendance doesn’t always mean high perceived value, with key exceptions in cardiology and oncology specialties. This infographic illuminates which conferences rank the highest in attendance and value across prominent medical specialties....
In this study, we explore the perceptions of US and Canadian physicians on conference attendance and CHE/CME events. The results highlight that while virtual events have become common, in-person conferences continue to provide significantly more value. Physicians prioritize interactive elements such as Q&A sessions, panel discussions, and case-based workshops, which enhance engagement and learning. The study also reveals the key factors that influence physicians' attendance, satisfaction, and what they expect from pharmaceutical companies to create a valuable conference experience. Discover more in our detailed infographic....
Ready to explore how data-driven insights can accelerate your pharmaceutical research? Connect with our team to discuss your goals.
